Clinical Trial Update: A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia [Phase 2]

View source ↗

Summary

This is a Phase II clinical trial update for perifosine in relapsed/refractory Waldenström's macroglobulinemia. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Waldenström's Macroglobulinemia | Phase 2 | Status: COMPLETED